A California woman was motivated to embark on a 3,000-mile walk to raise awareness of the power of healthy living. Judy ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease Research Center. The center’s brain bank is preserving more than 4,000 ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

But the exact mechanisms of how the drug works in the brain in doing things like tamping down food noise, addiction, and now, ...

Eisai Co.’s breakthrough Alzheimer’s drug Leqembi was cleared for use in the European Union, after the medicine was approved ...

A mountain region in Colombia was an epicenter of early-onset Alzheimer’s.. One researcher saw an opportunity to discover the ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

As more people get an early diagnosis, they face the difficult decision about when and how to reveal their condition.

A new AI Alzheimer's detection tool can listen to voice recordings and accurately determine if you'll develop the disease.

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.